Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

Sun, Hui‐Chuan; Zhou, Jian; Wang, Zheng; Liu, Xiufeng; Xie, Qing; Jia, Weidong; Zhao, Ming; Bi, Xinyu; Gong, Li; Bai, Xueli; Ji, Yuan; Xu, Li; Zhu, Xiao‐Dong; Bai, Dousheng; Chen, Yajin; Chen, Yongjun; Dai, Chaoliu; Guo, Rong; Guo, Wenzhi; Hao, Chunyi; Huang, Tao; Huang, Zhiyong; Li, Deyu; Li, Gang; Li, Tao; Li, Xiangcheng; Li, Guangming; Xiao, Liang; Liu, Jingfeng; Liu, Fubao; Lu, Shichun; Lu, Zheng; Lv, Wei‐Fu; Mao, Yilei; Shao, Guoliang; Shi, Ying–Hong; Song, Tianqiang; Tan, Guang; Tang, Yunqiang; Tao, Kaishan; Wan, Chidan; Wang, Guangyi; Wang, Lu; Wang, Shunxiang; Wen, Tianfu; Xing, Baocai; Xiang, Bang‐De; Yan, Sheng; Yang, Dinghua; Yin, Guowen; Yin, Tao; Yin, Zhenyu; Yu, Zhengping; Zhang, Bixiang; Zhang, Jialin; Zhang, Shuijun; Zhang, Ti; Zhang, Yamin; Zhang, Yubao; Zhang, Aibin; Zhao, Haitao; Zhou, Ledu; Zhang, Wu; Zhu, Zhenyu; Qin, Shukui; Shen, Feng; Cai, Xiujun; Teng, Gao‐Jun; Cai, Jianqiang; Chen, Minshan; Li, Qiang; Liu, Lianxin; Wang, Weilin; Liang, Tingbo; Dong, Jiahong; Chen, Xiaoping; Wang, Xuehao; Zheng, Shusen; Fan, Jia

doi:10.21037/hbsn-21-328

Public

Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

Published in HepatoBiliary Surgery and Nutrition • Feb 11, 2022

Authors:

Hui‐Chuan Sun

Jian Zhou

Zheng Wang

Abstract

Recent advances in systemic and locoregional treatments for patients with unresectable or advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This has provided an opportunity for selected patients with initially unresectable HCC to achieve adequate tumor downstaging to ...

Subject

Medicine

Hepatocellular carcinoma

Clinical Practice

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!